Rx Only Takeda PRINCIPAL DISPLAY PANEL - Kit Carton - 1500 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4627-01 Single-dose only For Intravenous Administration After Reconstitution Only Lyophilized powder for reconstitution ADYNOVATE and diluent preassembled in BAXJECT III system Rx Only Actual potency Takeda PRINCIPAL DISPLAY PANEL - Barrel Label - 1500 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Directions for use: see package insert Rx Only IU: LOT: EXP: Takeda 6521225 PRINCIPAL DISPLAY PANEL - Blister Label - 1500 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4627-02 Single-dose only 6521495 For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Do not open until time of use Do not use if packaging is opened or damaged Discard unused portion
The limited human data available has not shown significant safety concerns, but long-term human safety data is still being established
Frequency varies based on your needs, but many treatment plans range from weekly to monthly sessions
Lucena MI, Andrade RJ, de la Cruz JP, Rodriguez-Mendizabal M, Blanco E, Snchez de la Cuesta F
AAV-EGFP) was used as the vector control
doi: 10.1111/j.1468-1331.2006.01139.x
)
